Aug 232012
 

Reactive arthritis although not much commonly seen in pediatric practice is defined as a group of inflammatory arthritis which follow bacterial or viral infection particularly involving respiratory, gastrointestinal and genitourinary tracts.

Mode of Onset

Infection typically precedes development of arthritis by 1 to 4 weeks, with approximately 80% of cases being preceded by gastroenteritis.

Some Precipitating Organisms

Mycoplasma, Chlamydia, yersinia, Salmonella, Shigella, Campylobacter, Epstein barr virus, Parvovirus B19,and enteroviruses.

Clinical presentation

Patient presents with symptoms like fever, weight loss and fatigue as well as dermatological and opthalmological findings.  For example Reiter syndrome is a reactive arthritis in the presence of conjunctivitis and urethritis.

Association with HLA B 27

approximately 50 -65 % of cases have a strong association with HLA B 27.

Laboratory Studies

May demonstrate evidence of systemic inflammation including leukocytosis, thrombocytosis and elevated ESR and CRP. Autoantibodies are typically absent. Continue reading »

VN:F [1.9.20_1166]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.20_1166]
Rating: 0 (from 0 votes)
Share
Jul 232012
 

Raynaud Phenomenon (RP) refers to a transient vasospasm of peripheral arteries and arterioles that classically results in triphasic color changes in the affected region. The initial artery and arteriole vasospasm causes pallor (white), followed by cyanosis (blue) due to dilation of the capillaries and venous stasis (deoxygenated blood), with continued artery and arteriole vasospasm. The arteries and arterioles then dilate, causing rapid return of blood flow (red, reactive hyperemia). The fingers are the most commonly affected region, and Raynaud phenomenon is typically triggered by cold exposure or stress.

Raynaud phenomenon can be primary (idiopathic), meaning no associated diseases are present, or secondary, meaning that another condition is believed to be the cause of the Raynaud phenomenon. Connective tissue diseases are the most common cause of secondary Raynaud phenomenon, but several medications and many other conditions are also associated with Raynaud phenomenon.

Pathophysiology

The pathophysiology of Raynaud phenomenon is not completely understood; the vasospasm that occurs in the digital arteries, precapillary arterioles, and cutaneous arteriovenous shunts involves both central and peripheral mechanisms. The pathophysiology of secondary Raynaud phenomenon also involves structural changes to the vasculature that worsens the severity of the Raynaud phenomenon. Raynaud phenomenon can be thought of as an exaggerated normal response to cold and emotional stress.

Clinical Presentation

History form the patient

Patient history should include affected sites, frequency and severity of attacks, duration of attacks, color pattern, triggers, seasonality, and associated symptoms (ie, numbness, paresthesia, pain). The most commonly affected sites are the fingers, toes, ears, nose, and, rarely, nipples.The triggers of Raynaud phenomenon in children are similar to those described in adults. Cold and emotional stresses are the most common triggers; primary Raynaud phenomenon can also be triggered by exercise.Episodes are more common in the winter than in the summer, and serious ischemia is also more common in the winter.

Patients and their parents should be queried about changes in digits such as pits, ulcers, or poor healing, and about the presence of infection in affected digits. They should also be asked about possible associated or precipitating factors including frostbite, drug or toxin exposure, infection, vibration injury, family history of Raynaud phenomenon, family history of connective tissue diseases, history of migraine,weight loss or eating disorders, and cardiovascular diseases.

Patients should also be questioned for any history suggestive of connective tissue disease such as fever, fatigue, rash (malar, vasculitic, dermatomyositis), morning stiffness, Continue reading »

VN:F [1.9.20_1166]
Rating: 10.0/10 (1 vote cast)
VN:F [1.9.20_1166]
Rating: +1 (from 1 vote)
Share
Oct 012010
 

The treatment regimen depends on the affected target organs and disease severity. Sun exposure should be minimized and include use of a sunscreen. Patients are treated to promote clinical well-being, using serologic markers of disease activity as guidelines, including serum complement levels. Nonsteroidal anti-inflammatory agents, used to treat arthralgia and arthritis, are used with caution because patients with lupus are more susceptible to hepatotoxicity. Hydroxychloroquine is often used to treat mild manifestations including skin lesions, fatigue, arthritis, and arthralgia. Hydroxychloroquine may also reduce the risk of thromboembolic disease and lowers lipid levels.

Patients with thrombosis and antiphospholipid antibodies or a lupus anticoagulant should receive anticoagulant medication at least until lupus is in remission. The length of therapy is controversial. Low molecular weight heparin is the anticoagulant of choice; warfarin can also be used.

Corticosteroids control symptoms and autoantibody production in lupus. Treatment with corticosteroids has improved kidney disease and the rate of survival. Corticosteroids can make the diagnosis and treatment of tuberculosis difficult; all patients should have PPD and control skin tests, when possible, before corticosteroids are initiated. The optimal dose and route of administration of corticosteroids are controversial. Patients with systemic disease are often started on 1–2 mg/kg/24 hr of oral prednisone in divided daily doses. When complement levels increase to within the normal range, the dose is carefully tapered to the lowest effective dose. One method uses alternate-day high-dose corticosteroids once disease is controlled to prevent the Continue reading »

VN:F [1.9.20_1166]
Rating: 10.0/10 (1 vote cast)
VN:F [1.9.20_1166]
Rating: +1 (from 1 vote)
Share